glp-1 colorectal cancer death risk study november 2025 Weight-Loss Meds Linked to Improved Colon Survival GLP‐1 receptor agonists and the

Constipation Due to a lack of essential nutrients caused by restricted food intake, weight-loss drugs can lead to constipation, as the body doesnt receive the necessary nutrients to maintain proper digestive function

Semaglutide GLP-1 is a peptide that functions by mimicking the action of a hormone known as glucagon-like peptide 1 (GLP-1)

BMC Public Health (2009) 9:88

Snyder sheds light on the neurological, hormonal, and metabolic shifts that define this transition, while offering practical strategies for women to feel strong, supported, and empowered

BMJ Open Diab Res Care

The standard semaglutide timeline involves dose escalation roughly every four weeks, with most patients reaching maintenance doses of 1.0-2.4mg weekly